Dupont Capital Management Corp Global Blood Therapeutics, Inc. Transaction History

Dupont Capital Management Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$32.4 - $68.18 $309,970 - $652,278	9,567 New	9,567 $652,000
Q4 2020 Jan 28, 2021	SELL	$37.65 - $63.77 $197,850 - $335,111	-5,255 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$52.76 - $74.49 $58,405 - $82,460	-1,107 Reduced 17.4%	5,255 $290,000
Q2 2020 Jul 24, 2020	BUY	$48.73 - $81.82 $310,020 - $520,538	6,362 New	6,362 $402,000
Q1 2020 Apr 29, 2020	SELL	$41.72 - $87.2 $324,164 - $677,544	-7,770 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$45.35 - $57.91 $37,776 - $48,239	-833 Reduced 9.68%	7,770 $377,000
Q4 2018 Feb 01, 2019	BUY	$31.54 - $46.67 $31,476 - $46,576	998 Added 13.12%	8,603 $353,000
Q2 2018 Jul 30, 2018	SELL	$38.7 - $50.15 $380,924 - $493,626	-9,843 Reduced 56.41%	7,605 $344,000
Q1 2018 May 02, 2018	SELL	$39.6 - $65.9 $27,046 - $45,009	-683 Reduced 3.77%	17,448 $843,000
Q4 2017 Jan 31, 2018	BUY	$29.7 - $45.7 $538,490 - $828,586	18,131	18,131 $713,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.